First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations 
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Google Disrupts Major Residential Proxy Network IPIDEA 
Infosys Shares Drop Amid Earnings Quality Concerns 
Do investment tax breaks work? A new study finds the evidence is ‘mixed at best’ 
Insignia Financial Shares Hit 3-Year High Amid Bain and CC Capital Bidding War 
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Sam Altman Criticizes ICE Enforcement as Corporate Leaders Call for De-Escalation 
KiwiSaver shakeup: private asset investment has risks that could outweigh the rewards 
How the UK’s rollback of banking regulations could risk another financial crisis 
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift 
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
